Although similar to the Cho/NAA ratio (i.e., high Cho and low NAA tumor levels) in wild-type gliomas, the 2HG/Glx ratio may be more specific to detect the targeted treatment response against mutant IDH1 gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.